Total bids
9
9 including cancelled tenders
Awarded
5
2 lost · 0 still pending
Awarded value
₹78.1 L
of ₹1.7 Cr bid — 47.0% conversion
Win rate
55.6%
of 9 decided bids
Bid outcomes
How their decided bids ended, by number and by valueBy count9 bids
55.6%
22.2%
22.2%
Awarded555.6%
Pending00.0%
Tech rejected222.2%
Lost222.2%
By value₹1.7 Cr
47.0%
19.5%
33.4%
Awarded₹78.1 L47.0%
Pending₹00.0%
Tech rejected₹32.4 L19.5%
Lost₹55.5 L33.4%
Where they win
1 authority · 1 stateTop buyer organisations
Operating states
LowHigh
Top competitors
In tenders they both bid · bar shows how the awards splitRival awardedB. M. Pharma awardedOthers
Recent tenders awarded to B. M. Pharma
- Equipments for the ICMR NER Task Force New Scheme entitled Advanced Mycology Diagnostic and Research CentreHealth and Family Welfare Department · Assam · 2 Mar 2022₹13.3 L
- Advanced Molecular Diagnostic and Research CenterHealth and Family Welfare Department · Assam · 9 Dec 2021₹45.7 L
- ICMR SLE ProjectHealth and Family Welfare Department · Assam · 29 Oct 2021₹7.8 L
- Equipments for ICMR YDR ProjectHealth and Family Welfare Department · Assam · 5 Oct 2021₹10.4 L
- Advanced Molecular Diagnostic and Research CenterHealth and Family Welfare Department · Assam · 20 Aug 2021₹93,548
About B. M. Pharma
B. M. Pharma appears as a bidder on 9 government tenders on record, from 3 buyer authorities in 1 state. Of its 9 decided bids, it was awarded 5 — a 55.6% win rate — worth ₹78.1 L in total. Its most recent award on record is from 27 Mar 2026.
Its largest buyer by awarded value is Health and Family Welfare Department, at 100.0% of what it has won. Most of its awards come from Assam. On priced bids, its median quote is 2.7% above the lowest bid (L1).
It most often bids against Molbiogen, BIOAPPS and M/S SATI DRUGS and SURGICALS. Molbiogen bid on 4 of the same tenders and won 2 of them; B. M. Pharma won 3.